Researchers at Stanford Medicine have created a detailed map of how cells in the placenta change during pregnancy.
Researchers at Stanford Medicine discover an unknown quirk about the ribosome and make a sweet representation along the way.
Researchers at Stanford are devising new ways to deliver mRNA to the body to facilitate more potent and accurate treatments and vaccines.
This is Part I in a series that will explore the promise, challenges and future of mRNA. Let's count our blessings. The COVID-19 pandemic, from …
Researchers are harnessing an imaging technique called cryogenic electron microscopy to design drugs and better understand disease.
Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.
Researchers find that the ribosome, a protein-making machine, may contribute to diseases of aging, such as Alzheimer's and Parkinson's.
Stanford Medicine researchers found an element -- a prion -- that can control whether yeast cells and their progeny grow to large, or not.
A protein on a cell structure called the primary cilia links diabetes and obesity. The discovery may lead to new diabetes treatments.
A Stanford physician co-authored a list of likely biological factors underlying the reduced development of COVID-19 for children compared to adults.
Abdominal adhesions frequently occur after abdominal surgery. Stanford researchers prevented their formation in mice by blocking a molecular pathway.
Standard diagnosis of sepsis relies on a blood test that typically takes days. A Stanford physician is working on an innovation that could change this.
Stanford stem cell biologists have found a way to block a signal that causes growth of breast cancer cells, opening potential for new treatments.
Stanford-led research finds that the blood-brain barrier may be much more permeable -- albeit selectively so -- than previously thought.
Stanford researchers and colleagues have invented a genetic safety mechanism that can deactivate transplanted cells if they change in a problematic way.
Stanford researchers have found a good drug target for treating Diamond-Blackfan anemia, a genetic disease that impairs red blood cell formation.
